The multidimensional burden of hepatitis C and its treatment: A case study

Gastroenterology Nursing

Volumn 32, Issue 3, 2009, Pages 180-187

  Taylor Young, Patricia ^a   Hildebrandt, Eugenie ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

COST OF ILLNESS; DISEASE COURSE; ECONOMICS; HEPATITIS C; HOSPITALIZATION; HUMAN; HUMAN RELATION; LIVER CIRRHOSIS; MALE; MENTAL STRESS; MIDDLE AGED; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; COST OF ILLNESS; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HUMANS; INTERPERSONAL RELATIONS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 68549130890     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e3181a80655     Document Type: Article

References (27)

1. Alter, M. J. (1997). The epidemiology of acute and chronic hepatitis C. Clinics in Liver Disease, 1, 559-68, vi-vii.
2. Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus in the United States, 1999 through 2002. Annals of Internal Medicine, 144, 705-714.
3. Blasiole, J. A., Shrinkunas, L., LaBrecque, D. R., Arnould, R. M., & Zickmund, S. (2006). Mental and physical symptoms associated with lower social support for patients with hepatitis C. World Journal of Gastroenterology, 12, 4665-4672.
4. Brown, R. S., & Gaglio, P. J. (2003). Scope of worldwide hepatitis C problem. Liver Transplantation, 9(11), S10-S13.
5. Butt, A., Khan, U., McGinnis, K., Skanderson, M., & Kent Kwoh, C. (2007). Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. Journal of Viral Hepatology, 14(12), 890-896.
6. Department of Veterans Affairs Hepatitis C Resource Center; Yee, H. S., Currie, S. L., Darling, J. M., & Wright, T. L. (2006). Management and treatment of hepatitis C viral infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and National Hepatitis C Program office. American Journal of Gastroenterology, 101, 2360-2378.
7. Fireman, M., Indest, D., Blackwell, A., Whitehead, A., & Hauser, P. (2005). Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a comanagement model of care. Clinical Infectious Disease, 40(Suppl. 5), 286-291.
8. Fraenkel, L., McGraw, S., Wongcharatrawee, S., & Garcia-Tsao, G. (2006). Patients' experiences related to anti-viral treatment for hepatitis C. Patient Education and Counseling, 62, 148-155.
9. Glacken, M., Coates, V, Kernohan, G., & Hegarty, J. (2003). The experience of fatigue for people living with hepatitis C. Journal of Clinical Nursing, 12(2), 244-252.
10. Glacken, M., Kernohan, G., & Coates, V. (2001). Diagnosed with hepatitis C: A descriptive exploratory study. International Journal of Nursing Studies, 38, 107-116.
11. Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M. A., Hill, J., et al. (2002). A prospective study of the incidence and openlabel treatment of interferon-induced major depressive disorder in patients with hepatitis C. Molecular Psychiatry, 7(9), 942-947.
12. Hilsabeck, R. C, Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal of the International Neuropsychological Society, 9, 847-854.
13. Hilsabeck, R. C, Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35, 440-446.
14. Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.
15. Loftis, J., & Hauser, P. (2004). The phenomenology and treatment of interferon-induced depression. Journal of Affective Disorders, 82, 175-190.
16. McHutchinson, J. G., Manns, M., Patel, K., Poynard, T, Lindsay, K. L., Trepo, C, et al. (2002). Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology, 125, 1284-1286.
17. National Institutes of Health. (2002). NIH consensus statement on management of hepatitis C. NIH Consensus and State-of-the-Science Statements, 19(3), 1-46.
18. Olson, S., Iyer, S., Scott, J., Erez, O., Samuel, S., Markovits, T, et al. (2005). Cancer history and other personal factors affect quality of life in patients with hepatitis C. Health and Quality of Life Outcomes, 3, 39. Retrieved March 27, 2008, from http://www. hqlo.com/content/3/1/39
19. Raison, C, Barisov, A. S., Broadwell, S. D., Capuron, L., Woolwin, B. J., Jacobson, I., et al. (2005). Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and predication. The Journal of Clinical Psychiatry, 66(1), 41-48.
20. Rowen, P. J., Al-Jurdi, R., Tavakoli-Tabasi, S., Kunik, M. E., Satrom, S. L., & El-Serag, H. B. (2005). Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. Journal of Clinical Gastroenterology, 39(8), 731-736.
21. Shehab, T. M. (2004). Hepatitis C: An emerging epidemic. Gastroenterology, 6, 589-604.
22. Strader, D. B., Wright, T., Thomas, D. L., Seeff, L. B., & American Association for the Study of Liver Diseases. (2004). Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, 1147-1171.
23. Wong, J. B., McQuillan, G. M., McHutchison, J. G., & Poynard, T. (2000). Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health, 90, 1562-1569.
24. Zickmund, S., Bryce, C., Blasiole, J. A., Shrinkunas, L., LaBrecque, D. R., & Arnould, R. M. (2006). Majority of patients with hep- atitis C express physical, mental, and social difficulties with antiviral treatment. European Journal of Gastroenterology & Hepatology, 18, 381-388.
25. Zickmund, S., Hillis, S. L., Barnett, M. J., Ippolito, L., & LaBrecque, D. R. (2004). Hepatitis C virus-infected patients report communication problems with physicians. Hepatology, 39, 999-1007.
26. Zickmund, S., Ho, E. Y., Masuda, M., Ippolito, L., & LaBrecque, D. R. (2003). "They treated me like a leper." Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine, 18(10), 835-844.
27. Zucker, D. M., & Miller, B. W (2001). Assessment of side effects in patients with chronic hepatitis C receiving combination therapy. Gastroenterology Nursing, 24(4), 192-196.